mTOR kinase inhibitors (CNRS)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamemTOR kinase inhibitors (CNRS)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCNRS InnovationCentre National De La Recherche Scientifique (Cnrs)
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A